You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 18, 2024

CLINICAL TRIALS PROFILE FOR LEXAPRO


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for lexapro

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00071643 ↗ Preventing Post-Stroke Depression Completed National Institute of Mental Health (NIMH) N/A 2002-09-01 This study will evaluate the effectiveness of both drug and non-drug treatments in preventing depression after a stroke.
NCT00071643 ↗ Preventing Post-Stroke Depression Completed Robert G. Robinson N/A 2002-09-01 This study will evaluate the effectiveness of both drug and non-drug treatments in preventing depression after a stroke.
NCT00071643 ↗ Preventing Post-Stroke Depression Completed University of Iowa N/A 2002-09-01 This study will evaluate the effectiveness of both drug and non-drug treatments in preventing depression after a stroke.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for lexapro

Condition Name

Condition Name for lexapro
Intervention Trials
Depression 42
Major Depressive Disorder 41
Anxiety 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for lexapro
Intervention Trials
Depression 102
Depressive Disorder 92
Depressive Disorder, Major 63
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for lexapro

Trials by Country

Trials by Country for lexapro
Location Trials
United States 257
China 17
Canada 14
Korea, Republic of 9
Australia 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for lexapro
Location Trials
New York 27
California 19
Massachusetts 19
Pennsylvania 15
Texas 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for lexapro

Clinical Trial Phase

Clinical Trial Phase for lexapro
Clinical Trial Phase Trials
Phase 4 78
Phase 3 11
Phase 2/Phase 3 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for lexapro
Clinical Trial Phase Trials
Completed 113
Recruiting 16
Unknown status 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for lexapro

Sponsor Name

Sponsor Name for lexapro
Sponsor Trials
National Institute of Mental Health (NIMH) 34
Forest Laboratories 25
Massachusetts General Hospital 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for lexapro
Sponsor Trials
Other 183
Industry 52
NIH 50
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.